H.Res. 1271

H.Res. 1271: Expressing support for the designation of May 2026 as “Arthritis Awareness Month”.

Introduced Debbie Dingell (D) HOUSE_RESOLUTION — 119th Congress
Plain English Summary

H.Res. 1271 is a resolution expressing support for the designation of May 2026 as 'Arthritis Awareness Month'. The bill aims to raise awareness about arthritis, its impact on individuals and families, and the importance of research and education related to the condition.

Positive Media Summary

Media coverage has generally praised H.Res. 1271 for its focus on increasing awareness of arthritis, a condition that affects millions of Americans. Supporters highlight the importance of recognizing May 2026 as a time to educate the public and promote resources for those affected by arthritis.

Negative Media Summary

Some critics argue that while raising awareness is important, resolutions like H.Res. 1271 may be seen as symbolic gestures that do not lead to substantive policy changes or funding for arthritis research. Others feel that more urgent health issues should take precedence in legislative discussions.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The bill H.Res. 1271, which expresses support for the designation of May 2026 as 'Arthritis Awareness Month', does not exhibit any direct industry overlaps with the sponsor Debbie Dingell's top donor industries. This lack of overlap suggests that there are minimal financial interests directly influencing the bill's subject matter. While there is some lobbying activity in the broader policy area related to health and wellness, the disclosed amounts are not directly tied to the bill's focus on arthritis awareness. The only significant financial activity noted is from DIRSHU INTERNATIONAL, which contributed $100,000 through MERKAVA STRATEGIES CORPORATION, but this does not indicate a direct conflict since it is not specifically aligned with arthritis advocacy. Overall, the absence of direct financial ties to the bill's topic indicates a low risk of conflict of interest.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
DIRSHU INTERNATIONAL MERKAVA STRATEGIES CORPORATION $100,000
CEO WORKS SAUNDERS GLOBAL DIPLOMACY $45,000
KAZI IG SAUNDERS GLOBAL DIPLOMACY $15,000
SOUTHERN FOLGER CONTRACTING BBT STRATEGIES LLC $10,000
WATERFRONT GLOBAL BBT STRATEGIES LLC $5,200
DIGITALEUROPE VIVID STRATEGIES LLC undisclosed
INTERNATIONAL CHRISTIAN CHAMBER OF COMMERCE MERKAVA STRATEGIES CORPORATION undisclosed
DR. STEPHEN SOLOWAY MERKAVA STRATEGIES CORPORATION undisclosed
ONE ISRAEL FUND MERKAVA STRATEGIES CORPORATION undisclosed
HEMOGLOBIN OXYGEN THERAPEUTICS MERKAVA STRATEGIES CORPORATION undisclosed
ATAOLLAH AMINPOUR MERKAVA STRATEGIES CORPORATION undisclosed
HERSEL NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MORAD BEN NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MARK SCOTT MERKAVA STRATEGIES CORPORATION undisclosed
BORIS MINTS MERKAVA STRATEGIES CORPORATION undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Debbie Dingell, ranked by total contributions.

Health Professionals $160,000,000
Individuals: $160,000,000 PACs: $0
Retired $50,000,000
Individuals: $50,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us